Form 8-K - Current report:
SEC Accession No. 0000950137-04-007047
Filing Date
2004-08-24
Accepted
2004-08-24 08:01:39
Documents
7
Period of Report
2004-08-23
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT c87781e8vk.htm 8-K 15470
2 ARTICLES OF AMENDMENT TO ARTICLES OF INCORPORATION c87781exv3w1.htm EX-3.1 88192
3 FORM OF SUPSCRIPTION AGREEMENT c87781exv4w1.htm EX-4.1 149399
4 FORM OF COMMON STOCK PURCHASE WARRANT c87781exv4w2.htm EX-4.2 48175
5 ENGAGEMENT LETTER c87781exv10w1.htm EX-10.1 19761
6 WAIVER AND CONSENT c87781exv10w2.htm EX-10.2 13556
7 CONSENT AND AGREEMENT OF HOLDERS OF SERIES A c87781exv10w3.htm EX-10.3 260038
  Complete submission text file 0000950137-04-007047.txt   597141
Mailing Address 100 TRI STATE INTERNATIONAL SUITE 100 LINCOLNSHIRE IL 60069
Business Address 2500 MILLBROOK DRIVE BUFFALO GROVE IL 60089 8472796100
AKORN INC (Filer) CIK: 0000003116 (see all company filings)

EIN.: 720717400 | State of Incorp.: LA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-13976 | Film No.: 04993043
SIC: 2834 Pharmaceutical Preparations